Big Investors Are Buying Cara Therapeutics Stock. Should You?
Nearly half of Cara Therapeutics (NASDAQ: CARA) shares are owned by institutions. Another 15% of Cara stock is held by funds. Big investors are clearly very interested in the biotech.
Those big investors' interest in Cara Therapeutics appears to have grown over the past few months. According to Morningstar, institutional investors added significantly to their positions in Cara during the second quarter. Here's who's been buying the stock -- and, more importantly, why.
Image source: Getty Images.
Source: Fool.com
Blackrock Inc. Aktie
807,80 €
0,09 %
Die Blackrock Inc. Aktie erhält mehrere Buy-Einschätzungen, ohne eine Gegenstimme.
Ein positives, wenn auch bescheidenes, Potenzial für Blackrock Inc. mit einem Kursziel von 851 € im Vergleich zum aktuellen Kurs von 807.8 €.
